These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18206703)

  • 1. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment.
    Frei-Jones MJ; Baxter AL; Rogers ZR; Buchanan GR
    J Pediatr; 2008 Feb; 152(2):281-5. PubMed ID: 18206703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
    Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B
    Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.
    Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR;
    Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).
    Ibemere SO; Dubbs SB; Barnhart HX; Brown JL; Freiermuth CE; Kavanagh P; Paice JA; Strouse JJ; Wilkerson RG; Tanabe P;
    Contemp Clin Trials; 2021 Feb; 101():106252. PubMed ID: 33348066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department.
    Siewny L; King A; Melvin CL; Carpenter CR; Hankins JS; Colla JS; Preiss L; Luo L; Cox L; Treadwell M; Davila N; Masese RV; McCuskee S; Gollan SS; Tanabe P
    Blood Adv; 2024 Oct; 8(20):5330-5338. PubMed ID: 38815230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
    Tanabe P; Hafner JW; Martinovich Z; Artz N
    Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
    Tanabe P; Martinovich Z; Buckley B; Schmelzer A; Paice JA
    J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Return visit rates after an emergency department discharge for children with sickle cell pain episodes.
    Coleman KD; McKinley K; Ellison AM; Alpern ER; Hariharan S; Topoz I; Wurtz M; Nielsen B; Cook LJ; Morris CR; Brandow AM; Campbell AD; Liem RI; Nuss R; Quinn CT; Thompson AA; Villella A; King AA; Baumann A; Frankenberger W; Brousseau DC
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30553. PubMed ID: 37458568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.
    Knight LMJ; Onsomu EO; Bosworth HB; Crawford RD; DeMartino T; Glassberg J; Paice JA; Miller CN; Richardson L; Tanabe P
    Adv Emerg Nurs J; 2019; 41(1):86-97. PubMed ID: 30702538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and hospital practice variation for analgesia for children with sickle cell disease with vaso-occlusive pain episodes: An 11-year analysis.
    Eltorki M; Hall M; Ramgopal S; Chaudhari PP; Badaki-Makun O; Rees CA; Bergmann KR; Shapiro DJ; Gonzalez F; Phamduy T; Neuman MI
    Am J Emerg Med; 2024 Dec; 86():129-134. PubMed ID: 39427500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department.
    Schefft MR; Swaffar C; Newlin J; Noda C; Sisler I
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27274. PubMed ID: 29856534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain management in adults with sickle cell disease in a medical center emergency department.
    Solomon LR
    J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do children with sickle cell disease receive disparate care for pain in the emergency department?
    Zempsky WT; Loiselle KA; McKay K; Lee BH; Hagstrom JN; Schechter NL
    J Emerg Med; 2010 Nov; 39(5):691-5. PubMed ID: 19703740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD; McCavit TL
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
    Morris CR; Brown LAS; Reynolds M; Dampier CD; Lane PA; Watt A; Kumari P; Harris F; Manoranjithan S; Mendis RD; Figueroa J; Shiva S
    Blood; 2020 Sep; 136(12):1402-1406. PubMed ID: 32384147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.